Objective-To examine the traditional view that unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation in insulin dependent diabetes meilitus are manifestations of autonomic neuropathy.
Patients-23 Patients aged 21-52 with insulin dependent diabetes meilitus (seven with symptoms suggesting autonomic neuropathy, nine with a serious clinical problem with hypoglycaemia, and seven without symptoms of autonomic neuropathy and without problems with hypoglycaemia) and 10 controls with a similar age distribution, without a personal or family history of diabetes.
Main outcome measures-Presence of autonomic neuropathy as assessed with a test of the longest sympathetic fibres (acetylcholine sweatspot test), a pupil test, and a battery of seven cardiovascular autonomic function tests; adequacy of hypoglycaemic glucose counterregulation during a 40 mU/kg/h insulin infusion test; history of unawareness of hypoglycaemia; and response of plasma pancreatic polypeptide during hypoglycaemia, which depends on an intact and responding autonomic innervation of the pancreas.
Results-There was little evidence of autonomic neuropathy in either the 12 diabetic patients with a history of unawareness of hypoglycaemia or the seven patients with inadequate hypoglycaemic counterregulation. By contrast, in ali seven patients with clear evidence of autonomic neuropathy there was no-history of unawareness of hypoglycaemia and in six out of seven there was adequate hypoglycaemic counterregulation. Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation were significantly associated (p<0-01). The response of plasma pancreatic polypeptide in the diabetic patients with adequate counterregulation but without autonomic neuropathy was not significantly different from that of the controls (change in plasma pancreatic polypeptide 226-8 v 414 pmol/l). The patients with autonomic neuropathy had a negligible plasma pancreatic polypeptide response (3.7 pmol/l), but this response was-also blunted in the patients with inadequate
Introduction
Unawareness of hypoglycaemia in diabetic patients is, by tradition, ascribed to autonomic neuropathy. '13 Some patients with insulin dependent diabetes mellitus have been shown to produce inadequate amounts of adrenaline and glucagon in response to hypoglycaemia, and these patients are more at risk from neuroglycopenia and hypoglycaemic coma. 4 Diabetic autonomic neuropathy has also been suggested as the cause of defective adrenaline secretion in these patients,"7 and, in this way, as the cause of inadequate counterregulation. Previous studies investigating diabetic autonomic neuropathy and inadequate counterregulation have included only limited assessment of autonomic function, giving rise to conflicting results.89 We used an extensive battery of investigations of autonomic neuropathy to re-examine the relations among autonomic neuropathy, hypoglycaemic unawareness, and inadequate hypoglycaemic counterregulation.
Patients and methods

PATIENTS
If problems with hypoglycaemia are due to autonomic neuropathy patients with autonomic neuropathy would be expected to show evidence of such problems and, conversely, patients with such problems would be expected to show evidence of autonomic neuropathy. Thus our aims were to identify patients with unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation and assess them in detail for autonomic neuropathy and to identify patients with autonomic neuropathy and assess them for problems with hypoglycaemia. To facilitate identification of such patients, subjects dependent on insulin, recruited randomly from the routine hospital diabetic clinic, were invited to take part in the study if they fitted into one of three groups: group 1, with symptoms suggesting autonomic neuropathy (postural hypotension, gustatory sweating, gastroparesis, oesophageal atony, diarrhoea, neurogenic bladder, impotence, unexplained ankle oedema2); group 2, with a serious clinical problem with hypoglycaemia; group 3, without symptoms suggesting autonomic neuropathy and without a problem with hypoglycaemia. In total, 23 patients with insulin dependent diabetes mellitus were group 3). Table I shows their clinical characteristics. Ten controls of similar age distribution to the diabetic patients and with no personal or family history of diabetes were also studied.
METHODS
Samples of blood were taken for determination of haemoglobin A1 and creatinine concentrations. Diabetic retinopathy was assessed by non-mydriatic retinal photography'0 and ophthalmoscopy. I Cell function was assessed by the C peptide response to intravenous glucagon." All patients were asked whether they always had warning of hypoglycaemia, sometimes had no warning, or often had no warning; they then had an extensive autonomic assessment and an insulin infusion test 9 mmol/l in normal subjects to a mean of 4-3 mmol/l in patients with poorly controlled diabetes. 3 Amiel et al showed an appreciably lower threshold for triggering the release of adrenaline in diabetic patients with a mean haemoglobin Al concentration of 7-6% compared with those with a mean concentration of 11-5%. Particularly importantly, they showed that reducing haemoglobin Al concentration with intensive treatment in some of their patients with poorly controlled diabetes resulted in a lowering of the threshold for adrenaline release.
Though in our study the lower haemoglobin Al concentration in the group of patients with inadequate hypoglycaemic counterregulation did not achieve significance, the data are nevertheless in keeping with a hypothetical glucoregulatory centre, perhaps in the hypothalamus, which is failing to sense hypoglycaemia in the patients with defective counterregulation and therefore failing to trigger release of adrenaline and pancreatic polypeptide via the sympathetic and parasympathetic nervous systems.
